Drug Importation

13 Jul: Republican senator puts Canadian pharmacies back on the table

Early last week, the Big Pharma lobby proudly announced that it had cut a deal with the White House and that, as a result, President Obama would reneg on his promise to permit Americans, once and for all, to buy drugs from Canadian pharmacies. Late last week, Sen. David Vitter, a Louisiana Republican, tried to resurrect Canadian drug reimportation by adding it as an amendment to a $43 billion funding bill for the Department of Homeland Security. Political observers say the amendment is likely to be stripped from the final bill — but we’re quite sure that this political football will be kicked around a few more times before all is said and done. “There was a lot of opposition…

10 Jul: White House bargain with Big Pharma could hurt Canadian Pharmacies

Over the past few months, we here at eDrugSearch.com have been sometimes jubilant — and sometimes cautious — about the prospects of proposed legislation that, once and for all, would allow Americans to buy prescription drugs from licensed Canadian pharmacies. It should be a slam dunk. After all, President Obama is for it. Influential Republicans like John McCain are for it. Democrats, who control Congress, have been overwhelmingly for it for years. And of course, by every poll I’ve seen, between 70 and 80 percent of the American people are for it. Done deal, right? I’m afraid not. In fact, it’s beginning to look like the legalization of Canadian drug sales to Americans will once again fall into the legislative…

19 Jun: “Prospects for Legalizing Drug Reimportation to the United States”

A new U.K. report, “Prospects for Legalizing Drug (Re-)Importation to the United States“, has been released on the topic of U.S. citizens buying drugs from online Canadian pharmacies and other Tier One countries, such as the U.K., Australia and Japan. The report promises insight and analysis on these key questions: Will the drug reimportation bill pass? Where would supplies come from? What would be the risks and savings for consumers? What would be the risks and opportunities for industry players? The report, issued by London-based Report Buyer, presents itself this way: With public and private payers across the country seeking to save every healthcare dollar to get through the economic recession, [Sen. Byron] Dorgan senses a ‘bit of a tailwind’…